International Flavors & Fragrances Inc (IFF) and DuPont’s Nutrition & Biosciences (“N&B”) completed their €40.7bn merger yesterday (February 1st) and revealed a modernised identity for the new industry giant.
Israeli company NextFerm Technologies Inc. has raised $9.2 million in an initial public offering on the Tel Aviv stock exchange, the company announced today.
Start 2021 with insights from CEOs of some of the industry’s leading companies in a wide-ranging, interactive, and FREE webinar on NutraIngredients-USA.
Denmark’s Novozymes has announced the acquisition of Illinois-based Microbiome Labs, which offers a range of proprietary probiotic and microbiome solutions.
Bayer has announced the completion of its investment in Care/of, giving it a majority ownership in the personalized nutrition player. The deal deepens Bayer’s capabilities in the personalized healthcare and nutritionals space.
Ireland’s Kerry Group has acquired the Quebec family biotechnology company Bio-K+ International Inc., allowing the Bio-K+ brand to expand globally through Kerry.
Supplement giant GNC has canceled its bankruptcy auction and will move ahead to be acquired by Harbin Pharmaceutical Group Co., the company announced this morning.
Embattled supplement retailer GNC has started its passage through Chapter 11 bankruptcy, with some investment experts and brand owners bullish about the new GNC that will emerge from the process.
Nestlé Health Science has agreed to acquire a majority stake in Chicago-based Vital Proteins, adding the leading collagen brand to its other vitamin, mineral, supplement and wellness brands, including Atrium Innovations, Garden of Life, Pure Encapsulations...
Denmark’s Chr. Hansen Holding A/S has today entered into an agreement with the owners of Wisconsin-based UAS Laboratories LLC to acquire 100% of the B2B probiotics company.
The year is new and a lot of people are getting out their crystal balls. NutraIngredients-USA is no exception, and here are our top big issues that will impact the dietary supplements industry in this new decade.
A mega-merger between International Flavors & Fragrances Inc (IFF) and DuPont nutrition & biosciences unit will create a new industry giant worth more than $45 billion (€40.4 billion), say those involved in the deal.
Norwegian firm Epax is to invest €32m over the next two years in upgrading its facilities and capacity in response to consumer demand for high-potency omega-3 oils.
Dietary supplement manufacturer NOW has expanded its reach in the specialty multivitamin category by purchasing SuperNutrition, the company announced today.
Japanese chemical trading firm Nagase Group acquired Prinova, an Illinois-based manufacturer and distributor of food, beverage, and dietary supplement ingredients.
The world of hemp and CBD products sits at a critical moment in its history, much as the dietary supplement industry did a quarter century ago, according to one of the experts who was there at the birth of the industry.
Nutraceutical ingredient supplier DolCas BioTech has started a venture with India-based pharmaceutical and biotech company Tenshi Kaizen. The joint venture will focus exclusively on the research, development, and commercialization of nutraceutical products.
The supply of dietary ingredients is an earnings bright spot for Innophos as the company continues to transform from commodity chemicals supplier into a nutritional player.
Irish dairy and ingredients conglomerate Glanbia has continued its diversification into the ingredients space with the acquisition of US firm Watson for a reported $89 million.
Pfizer and GlaxoSmithKline are merging their consumer health units, bringing the two pharma giants’ dietary supplement and over-the-counter brands into what analysts are calling “the world’s largest consumer health company.”
French microbiome biotechnology firm Enterome has signed a global licensing, co-development and co-promotion agreement with major pharmaceutical player Takeda.
Liquid I.V., a development stage company that has found success with clever marketing of its hydration beverage, has secured $5 million in a star-studded private funding round.
Reckitt Benckiser and Kellogg are said to have joined the race to purchase GSK consumer nutrition business – with Nestlé, Unilever, Mondelēz and Coca-Cola already reportedly interested in the business.
Riding on the ‘clean label’ sports nutrition movement, beverage giant Coca-Cola announced that it is acquiring a minority stake in BodyArmor, structured to lead to a full acquisition.
From Clorox to Kirin to Johnson & Johnson, this year we’ve seen several consumer packaged goods (CPG) giants enter the dietary supplement space, either through acquisitions or major investments.
In its first foray into the supplement realm, Johnson & Johnson Consumer Inc. has acquired Zarbee’s, Inc., a manufacturer of dietary supplements and OTC remedies with Supplement Facts panels.
The founders of New Chapter have severed their relationship with Procter & Gamble because they said “financial pressures to accelerate profits” meant they could no longer in good conscience continue to associate themselves with the brand.
Global ingredients maker DuPont Nutrition & Health is divesting its alginates business to Germany-headquartered JRS Group, a specialist in functional additives and plant-based raw materials.
Since its acquisition of natural extract supplier Indfrag for $35 million last year, OmniActive Health Technologies is solidifying its presence in the US specialty botanicals and extracts market with a focus on healthy aging and healthy living.
CPG giant The Clorox Company has been growing its footprint in the dietary supplement space through acquisitions. During its recent earnings call, the company’s execs fielded questions concerning the logic behind its most recent purchase.
LabCorp announced today that it has entered a definitive agreement to sell its Covance Food Solutions business to Eurofins Scientific for $670 million.
Procter & Gamble will buy Merck KGaA’s consumer health unit for €3.4 billion euros – as the FMCG giant looks stem falling revenue by betting on vitamin ranges that have shown stable growth.
Supplement firm GNC looks set for considerable expansion in China, with Harbin Pharmaceutical Group Holding Co (Hayao) investing $300m to become the firm's largest single shareholder.
Chinese investment into Australian health firms, including supplement manufacturers, will continue to grow as the country's healthcare system matures and the population ages, analysts from KPMG are forecasting.
Innovation is happening at all levels of the dietary supplement industry and is carving out new paths to market, driven by the application of advanced statistical techniques, participants in a NutraIngredients-USA panel said.
